Physician

Alok A. Khorana, M.D.

According to 2025 Medicare claims, Alok Khorana, M.D. (NPI: 1912926346) practices medical oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Khorana is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Khorana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 108 traditional Medicare patients, billed 316 HCPCS/CPT codes, and received $20,297 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 208 prescription claims across 51 beneficiaries totaling $311,529 in drug costs, led by Imatinib Mesylate (Imatinib Mesylate). 2017 DME data shows 34 claims. Open Payments data shows 10 records totaling $26,751. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $21,331 and ending at $20,297. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $22,310 and ending at $311,529. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	94	286	$21,331
2016	124	387	$30,953
2017	93	285	$23,794
2018	115	274	$21,579
2019	154	529	$48,150
2020	123	324	$24,344
2021	113	277	$21,807
2022	109	274	$21,160
2023	90	218	$17,114
2024	108	316	$20,297

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	72	$22,310
2016	29	113	$133,468
2017	32	150	$220,973
2018	37	152	$313,018
2019	57	211	$111,407
2020	38	162	$278,077
2021	50	200	$143,036
2022	43	193	$144,883
2023	37	148	$225,259
2024	51	208	$311,529

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$2,943
2016	N/R	16	$881
2017	N/R	34	$14,380
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	30	30	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	12	26	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	56	143	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	29	38	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	26	31	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imatinib Mesylate	Imatinib Mesylate	12	380	$55,389
Eliquis	Apixaban	13	450	$8,532
Olanzapine	Olanzapine	21	700	$1,122
Omeprazole	Omeprazole	11	330	$92
Ondansetron Hcl	Ondansetron Hcl	15	150	$91

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$8,375	Regeneron Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$18,376	Cleveland Clinic Hospital
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alok A. Khorana, M.D.?

Tedicare shows public-source Medicare data for Alok A. Khorana, M.D. (NPI 1912926346), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alok A. Khorana, M.D. have ACO affiliation data?

Alok A. Khorana, M.D. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Alok A. Khorana, M.D.?

Alok A. Khorana, M.D. is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Alok A. Khorana, M.D. have Open Payments data?

Alok A. Khorana, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.